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Abstract
Background: Hepatitis E virus (HEV) infection is a zoonosis for which pigs play a role as a
reservoir. In Japan, the infection has been enzootic in swine. Clarifying the detailed mechanisms of
transmission within farms is required in order to facilitate an understanding of the age-specific
patterns of infection, especially just prior to slaughter.
Results: Here we reanalyze a large-scale seroprevalence survey dataset from Japanese pig farms
to estimate the force of infection. The forces of infection of swine HEV were estimated to be 3.45
(95% confidence interval: 3.17, 3.75), 2.68 (2.28, 3.14) and 3.11 (2.76, 3.50) [×10-2 per day] in
Hokkaido, Honshu and Kyushu, respectively. The estimates with our model assumptions indicated
that the average ages at infection ranged from 59.0–67.3 days and that the basic reproduction
number, R0, was in the order of 4.02–5.17. Sensitivity analyses of age-specific incidence at different
forces of infection revealed that a decline in the force of infection would elevate the age at infection
and could increase the number of virus-excreting pigs at the age of 180 days.
Conclusion: Although our estimates imply that more than 95% of pigs are infected before the age
of 150 days, the model shows that a decline in the force of infection could increase the risk of pig-
to-human transmission. If the force of infection started to decline, it might be necessary to
implement radical countermeasures (e.g. separation of uninfected pigs from infected herds
beginning from the end of the suckling stage) to minimize the number of virus-positive pigs at the
finishing stage.
Background
Hepatitis E virus (HEV) is a positive-strand RNA virus
without an envelope, which is classified as a member of
the genus Hepevirus in the family Hepeviridae [1,2]. The
virus is distributed worldwide, especially in the tropical
and subtropical regions of Asia, Africa and Latin America,
causing acute hepatitis in humans and is thus an impor-
tant public health problem [3]. HEV infection is a zoono-
sis mainly seen in humans and pigs [4-8]. In addition to
the maintenance of the virus in swine as a reservoir [9],
the infection is also seen in other primates [10-12]. The
virus is mainly transmitted via fecal-oral routes among
swine [13,14]. Whereas humans are also enterically
infected mainly through contaminated foods, a water-
borne outbreak can be caused if drinking water is contam-
inated with feces containing the virus [15].
Published: 10 May 2007
BMC Veterinary Research 2007, 3:9 doi:10.1186/1746-6148-3-9
Received: 11 January 2007
Accepted: 10 May 2007
This article is available from: http://www.biomedcentral.com/1746-6148/3/9
© 2007 Satou and Nishiura; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 9
(page number not for citation purposes)
BMC Veterinary Research 2007, 3:9 http://www.biomedcentral.com/1746-6148/3/9HEV infection in humans is seen not only in developing
countries but also in industrialized countries where spo-
radic cases of infection have been reported [16]. In partic-
ular, sporadic cases in various places and settings have
been reported in Japan [16-23]. Whereas deer have been
suggested to be a source of human infection [17,18],
ingestion of uncooked liver from wild boar is also fre-
quently reported as the cause of infection [19-23]. In addi-
tion to the habitual consumption of porcine liver in
Japan, it is important to note that the HEV infection is
enzootic in swine, facilitating the frequent occurrence of
pig-to-human transmission [12,24,25]. Seroprevalence
surveys in other industrialized countries have also dem-
onstrated the occurrence of virus transmission in swine
[14,26-30]. Although it is still yet to be fully clarified, pigs
are believed to be the natural host for the virus [5,10,16].
With these points in mind, it is essential to clarify the
detailed mechanisms of HEV transmission in swine. For
example, it would be very useful to know the average age
of individuals acquiring infection in enzootic areas and
the age-specific incidence, especially just prior to slaugh-
ter. Moreover, to identify effective control measures on
the farm (e.g., potential vaccination strategy [31]), it
would be necessary to quantify a key parameter of the
transmission, the basic reproduction number, R0, defined
as the average number of secondary cases arising from a
single primary case in a fully susceptible population. R0
gives an indication of the transmission potential, and
thus, is one of the most important epidemiologic determi-
nants [32,33]. For example, in a randomly mixing popu-
lation, a critical coverage of vaccination to eradicate a
disease, pc, can be derived by using R0; pc > 1-1/R0 [34]. In
enzootic areas, an estimate of R0 can be approximately
obtained by estimating the force of infection (i.e. the rate
at which susceptible individuals become infected), λ,
which is derived from age-specific seroprevalence data.
For nearly half a century, a catalytic model, the most clas-
sic type of force of infection model [35], has been applied
to seroprevalence and incidence data and various exten-
sions have been proposed [36-40].
The aim of this paper was to assess the transmission
potential of HEV infection in swine using seroprevalence
survey data from Japan. To clarify the age-specific mecha-
nisms of transmission in swine raised for human con-
sumption, published data [24] on age-specific
seroprevalence on pig farms was re-examined. With
respect to data from farms where pigs are slaughtered
immediately after the age of 180 days, there are two spe-
cific characteristics which required close epidemiologic
attention: (1) since the pigs at the suckling stage (i.e.,
younger than 30 days of age) are raised in separate hous-
ing from those in later stages, and due partly to a very
short-lived maternal antibody, those younger than 30
days are not exposed to infection [24,25], and (2) com-
pared to the demographic time scale (i.e. life expectancy
being 180 days), the time required for seroconversion is
relatively long and is not insignificant [9]. Thus, we pro-
pose our original modeling strategy assuming that expo-
sure starts at the age of 30 days and combining the explicit
estimate of the time required for seroconversion with a
simple model of the force of infection.
Results
Time required for seroconversion
A simple logit model was applied to the cumulative distri-
bution of the time required for seroconversion of anti-
HEV antibody based on inoculation experiments using
swine HEV [9]. Figure 1 compares the observed and pre-
dicted proportion of seroconversion with time post-inoc-
ulation. The maximum likelihood estimate of the median
time required for seroconversion was 25.0 (95% confi-
dence interval (CI): 20.9, 31.3) days. The coefficient of the
time after inoculation (for the logit model) was estimated
as 0.19 (95% CI: 0.11, 0.30). The χ2 goodness-of-fit test
did not reveal significant deviations between observed
and predicted frequencies (χ25 = 2.31, p = 0.81).
Estimates of the force of infection
The total sample sizes of seroprevalence surveys were
1400, 400 and 700 for Hokkaido, Honshu and Kyushu,
respectively [24]. The maximum likelihood estimates of
the force of infection, λ, (and the corresponding 95% CI)
of swine HEV for the three different geographic locations
in Japan were 3.45 (3.17, 3.75), 2.68 (2.28, 3.14) and
3.11 (2.76, 3.50) [×10-2 per day]. Expected values of λ
ranging from 2.68–3.45 ×10-2 day-1 indicate that the aver-
age time of infection ranged from 29.0–37.3 days after the
age of 30 days when individuals were first exposed to the
risk of infection (i.e. average age at infection was 59.0–
67.3 days). Observed and predicted age-specific seroprev-
alence are compared in Figure 2, confirming good overall
agreement of the model with the data. Although a signifi-
cant deviation was seen in Hokkaido (χ24 = 16.71, p <
0.01), this was not the case for Honshu (χ24 = 1.49, p =
0.89) or Kyushu (χ24 = 6.34, p = 0.17).
The population structure on pig farms in Japan is specific
in that individuals are slaughtered immediately after the
age of 180 days (i.e., 150 days after pigs are first exposed
to the risk of infection). This satisfied a reasonable
approximation of a simple age-specific survivorship func-
tion, referred to as Type I survivorship [32], to the data:
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basic reproduction number, R0, is approximated as the
product of the force of infection, λ, and the time from first
exposure to death, L (= 150 days) [32]:
R0 ≈ λL (2)
Thus, R0 (and the 95% CI) was estimated to be 5.17 (4.76,
5.62), 4.02 (3.43, 4.71) and 4.66 (4.13, 5.25) for
Hokkaido, Honshu and Kyushu, respectively.
Age-specific incidence at different forces of infection
Figure 3A shows the cumulative proportion of infected
individuals according to our simple assumptions with dif-
ferent forces of infection, λ, being 0.01, 0.03 and 0.05
(day-1). Accordingly, the average ages at infection, A (= 30
+ 1/λ), are 130, 63 and 50 days, respectively. Using this
range of λ, 0.03 (0.01, 0.05), it is predicted that 83.5 %
(45.1, 95.0) of the herd would be infected at the age of 90
days, 93.3 % (59.3, 98.9) at 120 days and 97.3 % (69.9,
99.8) at 150 days. Based on the same assumptions, Figure
3B shows the age-specific absolute incidence (i.e. the
number of newly infected individuals) at each given age in
a hypothetical herd with a population size of 1000.
Despite a few rough assumptions, the figure indicates that
average age at infection directly influences the age-specific
patterns of HEV incidence, enabling the prediction of inci-
dence shortly before the age of finishing (i.e. 180 days).
According to the above range of λ, the model predicts that
2.1 (4.1, 0.6) individuals would be newly infected at the
age of 120 days, 0.8 (3.0, 0.1) at 150 days and 0.3 (2.3,
0.0) at 180 days. In other words, the smaller the force of
infection is, higher the probability that virus excretion
would occur at the finishing stage.
Discussion
This study estimated the force of infection of swine HEV
for three geographic locations in Japan. For the estima-
tion, we incorporated two realistic aspects of swine HEV
transmission: (1) no exposure during the suckling stage
and (2) time delay of seroconversion after exposure to the
virus. As a result, the force of infection was estimated to be
approximately 0.03 day-1 implying that the average age at
infection is 63 days after birth. According to the estimates,
the basic reproduction number, R0, was in the order of 4–
5, which is relatively high compared to other diseases
[32,41]. To the best of our knowledge, this study is the
first to quantify the transmission potential of swine HEV
infection. Although the model needs a few rough assump-
tions, and despite limited precision of the observed data
(i.e. seroprevalence data was only collected monthly), our
model successfully provides similar estimates of λ for 3
discrete locations. Except for a slight deviation seen in
Hokkaido where the samples were taken from numerous
sub-regions in the large prefecture, the model adequately
explained the basic aspects of the age-specific pattern of
HEV seroprevalence in swine. Estimated force of infection
was highest in Hokkaido, the northernmost prefecture,
while Honshu revealed the lowest estimate. The force of
infection depends on various factors influencing trans-
mission (e.g. biological, environmental and demographic
factors). In particular, as the disease is transmitted
through virus contamination (i.e. fecal-oral route), breed-
ing methods and other determinants affecting exposure
are likely to influence the age-specific patterns of preva-
lence. Whereas the farms in Hokkaido were partly infested
with both genotypes III and IV, only genotype III was
observed in the other two regions. However, since these
two genotypes are immunologically crossreactive each
other [5,42], these could not be separately evaluated with-
out detailed information with respect to differences in
natural history and immune reaction.
There are two practical implications from our exercise.
First, estimation of the force of infection permitted clarifi-
cation of the average age at infection (being 63 days).
Although our model did not allow more detailed age- and
time-specificity of the force of infection to be derived due
to limited data [37-40], knowing the average age at infec-
tion enables clarification of the age-specific incidence of
infection (as shown in Figure 3), thereby providing a rea-
sonable assessment of the risk of HEV excretion in slaugh-
tered pigs. According to rigorous inoculation experiments
[9,13,43], swine HEV RNA can be detected in the liver,
feces, bile and other parts of the body as long as 30 days
Observed and predicted time required for seroconversion of anti-HEV antibodyFigure 1
Observed and predicted time required for serocon-
version of anti-HEV antibody. Logit model (line) was 
applied to the observed cumulative distribution of the time 
required for seroconversion (dot), which revealed a sigmoid 
pattern. Data source: ref. [9].Page 3 of 9
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ideally be infected sufficiently far in advance of reaching
150 days of age, so that the probability of virus excretion
will be extremely low at 180 days. Although our estimates
of the force of infection in Japan imply that the majority
of individuals (i.e., more than 95%) are infected before
the age of 150 days, it should be noted that any future
decline in the force of infection would increase the
number of virus-positive pigs at the age of 180 days. Thus,
most importantly, it must be remembered that a slight
decline in the force of infection could elevate the age at
infection and increase the risk of pig-to-human transmis-
sion. In addition to consumption of contaminated pork
by the general public, the increased risk of infection could
also be a particularly risk for veterinarians and boar meat
processing workers [44,45]. If the force of infection is nat-
urally reduced on the farm, this could necessitate radical
control measures to minimize the number of virus-excret-
ing pigs at the finishing stage and to eliminate the trans-
mission from the farm. Since the population dynamics
model can account for more detailed mechanisms of
transmission [46-48], further explicit clarification on this
point is a subject of our further studies. Although the time
required for seroconversion may be slightly underesti-
mated (because of the estimation using intravenous inoc-
ulation rather than that through oral routes), this
Observed and predicted age-specific seroprevalence against swine hepatitis E virus in JapanFigure 2
Observed and predicted age-specific seroprevalence against swine hepatitis E virus in Japan. Observed (gray bar) 
and predicted (black) seroprevalence are compared. Three discrete geographic areas, Hokkaido (A), Honshu (B) and Kyushu 
(C), are modeled separately. Data source: ref. [24].Page 4 of 9
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tion of the force of infection, and thus, the above qualita-
tive discussion of the results and their implications is still
valid.
Second, the critical coverage of vaccination required for
eradication, pc, is obtained from R0, using pc > 1-1/R0 [34].
Although vaccines are currently under development [31],
our estimate of R0, ranging from 4.02–5.17, suggests that
the HEV transmission on the farm could be prevented if
more than 75.1–80.7 % of the pigs were successfully
immunized. However, since HEV infection in man is
likely to result in asymptomatic or mild disease [3,16,49],
and because pig-to-human transmission could be partly
prevented by dietary changes of humans (i.e. avoiding
consumption of fresh liver), potential future vaccination
policies for swine need to take account of cost-benefit
analyses and the biological feasibility of elimination. For
example, the maintenance of the virus by other primates
could prevent the elimination of virus transmission in
swine [3,10]. Rather, if it becomes necessary to implement
radical control measures, it may be more realistic and less
costly to control the transmission within a herd at specific
stages; considering that more than four-fifths of infection
had happened between the ages of 30 and 90 days, tem-
poral separation of uninfected young pigs from infected
herds beginning from the end of suckling stage (e.g. for a
certain time period, breed the individuals in a new house)
could limit the chance of continued transmission. In this
case, tight management of newly-built pig farms (i.e. pre-
vention of contamination from other locations and ani-
mals) combined with the possibility of vaccination in the
future might be necessary to reduce transmission within
the herd.
Conclusion
The force of infection of swine HEV was estimated from
three discrete geographic locations in Japan using age-spe-
cific seroprevalence data. The estimates ranged from 2.68–
3.45 ×10-2 (day-1), indicating that R0 ranges from 4.02–
5.17. The estimates permitted a reasonable prediction of
the age-specific incidence including that at the finishing
stage. Although our estimates of the force of infection
imply that more than 95% are infected before the age of
150 days and the probability of virus-excretion is small at
180 days, the model suggests that a decline in the force of
infection could elevate the average age at infection and
increase the risk of pig-to-human transmission. If the
force of infection started to decline, it might be necessary
to implement radical countermeasures (e.g. separation of
uninfected pigs from infected herds beginning from the
end of the suckling stage) to minimize the number of
virus-positive pigs at the finishing stage. As this study
showed a reasonable estimation in Japan which is an
enzootic area for swine HEV infection, similar seropreva-
lence survey would be extremely useful to decipher the
Cumulative frequency of infection and age-specific incidence at different forces of infectionFigure 3
Cumulative frequency of infection and age-specific incidence at different forces of infection. A. Cumulative fre-
quencies of HEV infection and B. age-specific incidence elicited by different forces of infection are compared. Assumed values 
for the forces of infection were 0.01 (thick black), 0.03 (thin black) and 0.05 (thick gray) days-1. See eqs. 6 and 7 for details of 
the model.Page 5 of 9
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studies of swine, human and other animals with time,
space and age as well as among specific groups [44,45]
could shed further light on the transmission dynamics of
HEV.
Methods
Data
To estimate the force of infection, this study used two
published datasets: (1) an experimental inoculation study
of swine HEV [9], and (2) a large-scale seroprevalence sur-
vey in Japan [24]. The experimental study recorded the
time required for seroconversion of anti-HEV antibody
following inoculation. The seroepidemiologic study con-
sisted of a survey of pig farms in three discrete geographic
locations (Hokkaido, Honshu and Kyushu; see Figure
4A). Anti-HEV IgG antibodies of 2500 pigs were measured
by age group. The original study examined the age-specific
seroprevalence by month, i.e., pigs at 60, 90, 120, 150 and
180 days of age (allowing ± 5 days variation for each) were
sampled [24]. We used this data because the detailed
breeding methods of the piggery in Japan were known and
the sample size was sufficiently large to allow statistical
analysis. On the farm, a proportion of the suckling herd
has a very short-lived maternal antibody (Tsunemitsu H,
personal communication) and is not exposed to infection
due to separate housing during this stage. A seroepidemi-
ologic study and an isolation study of HEV RNA during
natural infection in other countries also roughly satisfied
this assumption: the number of seropositive pigs was neg-
ligible at the age of 30 days on several farms [50] and HEV
RNA started to be detected at the age of 30 days [51]. Since
the pigs thereafter entered into weaning, growing and fat-
tening stages, we assume that the risk of exposure starts at
the age of 30 days. The pigs are slaughtered immediately
after the age of 180 days.
Estimation of the time required for seroconversion
Cumulative distribution of the time required for serocon-
version, G(t) at t days post-inoculation was approximated
by a simple logit model:
Estimation of the force of infection of hepatitis E virus in JapanFigure 4
Estimation of the force of infection of hepatitis E virus in Japan. A. The map of three geographic locations in Japan 
(drawn by the authors). B. Compartment of the catalytic model. Susceptibles at age a, S(a), are infected at a rate λ and then 
enter into the compartment, infected, I(a). C. Schematic illustration of the time delay to seroconvert. If the time of serocon-
version t0 and possible time of exposure tk are given, probability of exposure at time tk can be extracted by g(t0-tk), where g(t) is 
the probability density of the time required for seroconversion at t days after infection. See eqs. 9 and 10 for statistical details.Page 6 of 9
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l = b(t - tm) (4)
where b is the coefficient of the time since inoculation and
tm is the median time required for seroconversion. In
order to apply a logistic curve to the cumulative distribu-
tion, the model has to satisfy G(0) ≈ 0 and G(∞) = 1. The
maximum likelihood estimates of b and tm were obtained
by minimizing the binomial deviance of the model from
the observed data. The 95% CI were determined by using
the profile likelihood.
Force of infection
For simplicity and due to limited data availability, we
assumed that the force of infection, λ, was independent of
time (i.e. endemic equilibrium). Furthermore, except for
an assumption that no exposure occured during the suck-
ling stage (i.e. until the age of 30 days), λ was also
assumed to be age-independent. Figure 4B shows a sche-
matic illustration of the model. We denote the propor-
tions of susceptible and infected individuals at age a days
(for a ≥ 30) by S(a) and I(a), respectively. With an initial
condition, S(30) = 1 and I(30) = 0, the model is given by
the following ordinal differential equations:
for a ≥ 30. The analytical solution is given by:
I(a) = 1-exp{-λ(a-30)} (6)
for a ≥ 30. Under the same assumption, age-specific inci-
dence, C(a), at age a, is given by product of λ and S(a):
In addition to the estimation of λ, we examined the sensi-
tivity of I(a) and C(a) to the different values of λ to
explore the age-specific patterns and clarify the practical
implications of λ to farm management.
Convolution equation and maximum likelihood estimation
Since all individuals are slaughtered immediately after the
age of 180 days, the time delay from infection to serocon-
version was thought to be non-negligible. That is, the age-
specific seroprevalence data (at age a days) does not
directly reflect all of those who were infected until age a,
I(a), but rather indicates those infected until the age
which is smaller than a. Thus, to account for the delay, we
used probability density of the time to seroconvert (Figure
4C) in addition to the model of the cumulative distribu-
tion of HEV infection (Eq. 6). Considering the time-scale
of the distribution of time to seroconvert (Figure 1) and
the cumulative incidence up to the age of 60 days (Figure
2), we assumed that those seropositive at the age of 60
days approximately reflected those who were infected
until the age of 45 days. Under these assumptions, the
age-specific incidence density, fi, whose infection is
reflected as seropositive at i months after starting to be
exposed (i.e., a = 30(i + 1) days) is assumed to be:
Using the same mid-point of the time-interval, the proba-
bility density of time to seroconvert, gj, at j months after
infection was also approximated by using G(t):
The density of those who newly showed seropositive
results at the age of 60 days (i.e., at i = 1 month), k1, is
given by k1 = f1g1. In the same way, the densities at the ages
of 90 and 120 days, k2 and k3, are given by k2 = f2g1 + f1g2
and k3 = f3g1 + f2g2 + f1g3. This can be generalized by using
the following convolution equation [52-54]:
Since the observed seroprevalence data shows the cumu-
lative distribution of those seroconverted after infection
until month i, Ki, which is given by , we get:
where . Suppose that there were Ni pigs who
had been seropositive until month i (where i = a/30 - 1)
and Mi who had not, the likelihood function is
The maximum likelihood estimate of λ is obtained by
minimizing the negative logarithm of Eq. 12. The 95% CI
G t
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data were analyzed using the statistical software JMP IN
ver. 5.1 (SAS Institute Inc., Cary, NC).
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